All In MedTech

Device Trial Radar · NCT04950959

XACT ACE Observational Registry

Observational Post-Market Study of the XACT ACE Robotic System

Last checked: Nov 20, 2026Latest source record: Oct 21, 2022 (this record)Source: ClinicalTrials.govMethods & limitations

Status unknown

Status

Status unknown

Enrollment

500

Planned (sponsor's estimate)

Start

Oct 1, 2021

Primary completion

Jul 1, 2026

Study completion Aug 1, 2026

Sponsor

Lead sponsor
Xact Robotics Ltd.Not on our public-company list
Sponsor type
Industry
First posted
Jul 6, 2021

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
No
Who can join
All sexes, from 18 years

Summary

As written by the sponsor on the registry.

Compile real world data on the use of the XACT ACE Robotic System

Conditions

  • Tumors

Interventions

  • Hands-free, user-controlled robotic system intended to assist in the planning and advancement of an instrument during CT guided percutaneous procedures. TDevice

    The system is used for trajectory planning and is intended to assist the physician in the positioning of an instrument, such as a needle, where CT imaging is used for target trajectory planning and intraoperative tracking. The XACT ACE Robotic System uses a computerized quantitative guidance system, which provides real-time, accurate needle guidance, including advancement and steering of the needle from the entry point on the subject's body to the target point within the body.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Proportion of successful proceduresTime frame: 1 hour

2 more outcomes with a free account

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Lahey Hospital and Medical Center

    Burlington, Massachusetts · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.